Breast Cancer Tumor Response to Neoadjuvant Chemotherapy measured
Saturday, October 25, 2014 - 03:31
in Health & Medicine
It may be possible to use Diffuse Optical Spectroscopic Tomographic imaging (DOST) to predict which patients will best respond to chemotherapy used to shrink breast cancer tumors before surgery, a study shows.